Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors | stella

Back to Pancreatic Cancer trials

Recruiting

Trial locations(1 site)

China

Wuhan Union Hospital, China, Wuhan, Hubei

Key details

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Enrollment target

~26 participants

Started

April 2026

Primary completion

March 2027

Age range

18 Years and older

Last updated on clinicaltrials.gov in April 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Xiaoli Lan, PhD

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Enrollment status is pulled from ClinicalTrials.gov and may not reflect real-time availability. If a trial appears full when you reach out, the team will let you know.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov